March 11th, 2009, by David Pascoe | patents, sansrosa
A new sansrosa patent application has appeared, and from it was can see clearly what formula will be used for the sansrosa gel and sansrosa cream formulations. We don’t know the official name for the product yet, but it seems to make sense to me to call the product Sansrosa Gel and Sansrosa Cream.
Those following the development of sansrosa closely will be encouraged by this …
March 10th, 2009, by David Pascoe | research
Continuing our Rosacea Expert series, the Rosacea Support Resource Pages now has a summary of the ongoing Ask a Doctor IPL & Laser sub-forum. Have a read of Laser & IPL: Dr. Peter Crouch, MB.BS, Dr Steve Johnson, MD, Dr. Nicholas Soldo, MD to find out more about the following questions; ACCUTANE WITH RED LIGHT …
March 6th, 2009, by David Pascoe | clinical trials, finacea, oracea
The Clinical Trials register has listed a new trial for papulopustular rosacea. The trial, sponsored by Intendis, the manufacturer of Finacea, wants to compare the combination of Oracea and Finacea, with the combination of Oracea and Metrogel 1%.
It seems clear from this that Intendis would like to position Finacea as a viable …
March 5th, 2009, by David Pascoe | in the news
The 67th Annual Meeting of the American Academy of Dermatology is due to meet this week in San Francisco. I have to say that the AM09 Program looks a little uninteresting for those following rosacea developments. The program contains a few advertisements from Finacea, the new Instant Relief Mineral Powder from the Clinique Redness Solutions range and also Aczone …
